PIGA, ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 6.688
AS - Asia 4.561
EU - Europa 4.447
SA - Sud America 730
AF - Africa 69
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.506
Nazione #
US - Stati Uniti d'America 6.504
SG - Singapore 1.381
IT - Italia 1.360
CN - Cina 1.124
VN - Vietnam 842
HK - Hong Kong 737
DE - Germania 666
RU - Federazione Russa 628
BR - Brasile 594
IE - Irlanda 517
SE - Svezia 449
GB - Regno Unito 215
AT - Austria 126
CA - Canada 116
UA - Ucraina 97
IN - India 96
ID - Indonesia 85
FR - Francia 81
NL - Olanda 57
AR - Argentina 56
FI - Finlandia 54
KR - Corea 54
JP - Giappone 48
PL - Polonia 46
MX - Messico 42
BD - Bangladesh 36
DK - Danimarca 36
ES - Italia 35
ZA - Sudafrica 33
TR - Turchia 28
EC - Ecuador 24
BE - Belgio 15
LT - Lituania 14
PY - Paraguay 14
IQ - Iraq 13
TW - Taiwan 13
CO - Colombia 11
IR - Iran 11
CH - Svizzera 10
VE - Venezuela 10
AU - Australia 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
IL - Israele 8
MA - Marocco 7
MY - Malesia 7
PK - Pakistan 7
TH - Thailandia 7
UY - Uruguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
PE - Perù 6
CL - Cile 5
EG - Egitto 5
KZ - Kazakistan 5
OM - Oman 5
PH - Filippine 5
PT - Portogallo 5
AL - Albania 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
PA - Panama 4
RO - Romania 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
KW - Kuwait 3
LB - Libano 3
LV - Lettonia 3
NP - Nepal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BY - Bielorussia 2
ET - Etiopia 2
GA - Gabon 2
HR - Croazia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
Totale 16.494
Città #
Ann Arbor 1.300
Singapore 868
Hong Kong 726
Ashburn 637
Milan 563
Dublin 506
Frankfurt am Main 466
Chandler 458
Fairfield 350
Wilmington 311
New York 233
Ho Chi Minh City 219
Dearborn 208
Dallas 207
Santa Clara 200
Hanoi 196
Beijing 163
Woodbridge 157
Los Angeles 156
Seattle 145
Cambridge 138
Princeton 135
Houston 132
Hefei 126
Shanghai 117
Dong Ket 116
Vienna 86
Nanjing 72
São Paulo 66
Moscow 63
Jakarta 62
Kent 48
Munich 48
Seoul 48
Jacksonville 46
The Dalles 45
Buffalo 43
Chicago 42
Nuremberg 40
London 35
Montreal 34
Tokyo 34
Denver 33
Toronto 32
Guangzhou 31
Warsaw 31
Brooklyn 30
Lawrence 28
Nanchang 28
Altamura 26
Madison 26
Caronno Pertusella 25
Changsha 25
Helsinki 25
Shenyang 25
Fremont 24
Poplar 24
Florence 22
Ha Long 21
Hải Dương 21
Lissone 21
Ottawa 21
Da Nang 20
Hebei 20
Zhengzhou 20
Cagliari 19
Rome 19
San Diego 19
Tianjin 19
Chennai 18
Jinan 18
Andover 17
Cinisello Balsamo 17
Haiphong 17
Orem 17
Pavia 17
Rio de Janeiro 17
Atlanta 16
Belo Horizonte 15
Quận Bình Thạnh 15
Stockholm 15
Turku 15
Falls Church 14
Ningbo 14
Phoenix 14
Salt Lake City 14
San Francisco 14
Austin 13
Brussels 13
Mexico City 13
Romola 13
Amsterdam 12
Brasília 12
Lappeenranta 12
Pune 12
Jiaxing 11
Manchester 11
Monza 11
Council Bluffs 10
Paris 10
Totale 10.737
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 536
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 482
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 459
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 426
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 379
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 376
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 349
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 339
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 326
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 321
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 314
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 314
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 310
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 307
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 301
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 297
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 274
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 269
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 257
A molecular imaging approach to individuate tumour infiltrating lymphocytes 244
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 242
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 233
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 229
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 223
Proteomics tools and mass spectometry imaging techiques for the molecular characterization of pancreas 212
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 209
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 207
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 206
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 201
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 199
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 195
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 193
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 193
Putative salivary biomarkers useful to differentiate patients with fibromyalgia 192
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 191
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 189
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 186
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 185
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 179
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 178
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 172
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 167
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 165
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 158
Glucagon-like peptide 1 protects INS-1E mitochondria against palmitate-mediated beta-cell dysfunction: A proteomic study 157
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 155
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 153
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 150
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 148
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 144
Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid 143
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 142
MALDI-MSI as complementary tool in the characterization of thyroid nodules: novelties and challenges in the evolving landscape of diagnostic pathology 141
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 140
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 139
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 139
Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection 134
Recent advances in MALDI mass spectrometry imaging: a cutting edge tool for the diagnosis of thyroid nodules 134
C0513: A Non-Invasive Approach for Monitoring Patients Undergoing Anticoagulant Therapy 133
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 129
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 127
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 126
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 126
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 124
High resolution MALDI-FTICR-MSI analysis of intact proteins in mouse pancreas tissue 118
Development of mass spectrometry imaging methods for the analysis of intact proteins in mouse pancreas tissues by MALDI-TOF-MS and MALDI-FTICR-MS 118
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 116
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 114
Determination of anticoagulant drugs and their metabolites in oral fluid: strategies for sample collection 113
High resolution MALDI-FTICR-MSI analysis of intact proteins in mouse pancreas tissue 113
Comparative proteomics of native tuscany cultivars of olea europaea: a preliminary study 112
Determination of Warfarin and Warfarin alcohols in oral fluid and plasma samples for monitoring patients undergoing anticoagulant therapy 111
Influence of sampling on the measured concentration of Warfarin and Warfarin alcohols in oral fluid 110
Determination of Warfarin and Warfarin alcohols in saliva and plasma by high performance liquid chromatography with fluorimetric detection 110
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 110
Determination of anticoagulant drugs and their metabolites in oral fluid and plasma samples by HPLC-Fluorimetry 109
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 109
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 109
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 104
MALDI-MS Imaging Application in Thyroid FNA: Challenges and Perspectives 101
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 101
Glucagon-like peptide-1 protects INS-1E against palmitatemediated β-cell dysfunction: a proteomic study 100
New insights in MSI pathology: a molecular snapshot of thyroid cancer 99
Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study 98
Does the urinary proteome reflect ccrcc stage and grade progression? 97
Machine Learning Ensemble Algorithms for Classification of Thyroid Nodules Through Proteomics: Extending the Method of Shapley Values from Binary to Multi-Class Tasks 86
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 85
Advances in thyroglobulin measurement: exploring dried blood spot sampling and mass spectrometry for enhanced clinical utility 81
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 79
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 73
Recent Advances in MALDI Mass Spectrometry Imaging: A Cutting-Edge Tool for the Diagnosis of Thyroid Nodules 53
Elaboration Pipeline for the Management of MALDI-MS Imaging Datasets 41
Well Begun Is Half Done: The Impact of Pre-Processing in MALDI Mass Spectrometry Imaging Analysis Applied to a Case Study of Thyroid Nodules 16
Totale 17.154
Categoria #
all - tutte 56.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.166 0 0 0 0 0 218 165 207 118 110 99 249
2021/20221.078 96 98 59 128 60 91 9 60 44 95 115 223
2022/20231.981 219 504 220 162 96 271 21 129 165 34 88 72
2023/20241.632 52 53 78 114 165 447 325 46 130 26 58 138
2024/20253.411 152 277 226 165 278 140 202 95 412 599 308 557
2025/20264.864 1.190 632 757 1.188 1.048 49 0 0 0 0 0 0
Totale 17.154